Health & Personal Care
HIGH
FDA DEVICE
Meridian Bioscience Recalls Revogene C. difficile Assay Over False-Negative Risk
Meridian Bioscience recalled 211 units of the Revogene C. difficile diagnostic assay on December 5, 2025. Users may experience false-negative results due to a decline in performance over time. Patients and healthcare providers must stop using the device immediately.
Meridian Bioscience
The affected